ANVISA registration

PROSTATE SPECIFIC ANTIGEN (tPSA)

Registration 80048490015. ANTÍGENO PROSTÁTICO ESPECÍFICO (PSA)

Registration details

Registration number80048490015
Application number25351263442200618
Technical nameANTÍGENO PROSTÁTICO ESPECÍFICO (PSA)
Risk classIII
Published on30/10/2006
ValidityValid until 30/10/2036

Registration holder

Legal nameUSA DIAGNOSTICA LTDA
CNPJ02.330.159/0001-08

Manufacturer

  • MONOBIND, INC ESTADOS UNIDOS DA AMÉRICA

Other registrations held by USA DIAGNOSTICA LTDAview all

CARCINOEMBRYONIC (CEA)

80048490013

PROLACTIN (hPRL)

80048490016

FREE PROSTATE SPECIFIC ANTIGEN (fPSA)

80048490017

HUMAN CHORIONIC GONADOTROPIN (hCG)

80048490018

LEITOR CLIA

80048490019

IMUNOGLOBULINA E (IgE)

80048490025

Source: ANVISA

Source: ANVISA open data, medical device file, updated daily. The public database provides registration validity, rather than registration status: this registration may have been cancelled before its expiry date without this being shown here. Before making purchasing, import or marketing decisions, check the ANVISA search portal.

Next step

Medical device registration with ANVISA

HSC manages the process from risk classification to liaising with the regulator, in Brazil and more than 40 other countries.

Speak to a specialist